Clinical Trial Update: Use of Ziv Aflibercept in Different Retinal Diseases [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update on ziv Aflibercept for retinal diseases, specifically central retinal vein occlusion with macular edema, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Retinal Vein Occlusion with Macular Edema

Drugs mentioned

• Ziv-aflibercept (ziv-aflibercept)

Snippet

Sponsor: Amin El Sayed Nawar | Conditions: Central Retinal Vein Occlusion With Macular Edema | Phase 1, Phase 2 | Status: COMPLETED